Our results demonstrate that increases in the mRNA levels of Fbxo32 and Trim63 E3 ligases are sufficient to manifest a reduction in the CSA, the gold standard for detecting muscle atrophy. The gene discussed is FBXO32; the disease is muscle atrophy.